Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38


Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer.

Jeitany M, Leroy C, Tosti P, Lafitte M, Le Guet J, Simon V, Bonenfant D, Robert B, Grillet F, Mollevi C, El Messaoudi S, Otandault A, Canterel-Thouennon L, Busson M, Thierry AR, Martineau P, Pannequin J, Roche S, Sirvent A.

EMBO Mol Med. 2018 Apr;10(4). pii: e7918. doi: 10.15252/emmm.201707918.


Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of β-lactams administered by continuous infusion: a prospective observational study.

Carrié C, Petit L, d'Houdain N, Sauvage N, Cottenceau V, Lafitte M, Foumenteze C, Hisz Q, Menu D, Legeron R, Breilh D, Sztark F.

Int J Antimicrob Agents. 2018 Mar;51(3):443-449. doi: 10.1016/j.ijantimicag.2017.11.013. Epub 2017 Nov 24.


Early liver metastases in resectable periampullary cancer: Incidence and risk factors.

Guerard AS, Ayav A, Busby H, Lafitte M, Rousseau H, Laurent V.

Eur J Radiol. 2017 Aug;93:265-272. doi: 10.1016/j.ejrad.2017.06.005. Epub 2017 Jun 9.


Design of a small molecule against an oncogenic noncoding RNA.

Velagapudi SP, Cameron MD, Haga CL, Rosenberg LH, Lafitte M, Duckett DR, Phinney DG, Disney MD.

Proc Natl Acad Sci U S A. 2016 May 24;113(21):5898-903. doi: 10.1073/pnas.1523975113. Epub 2016 May 11.


Therapeutic targeting of casein kinase 1δ in breast cancer.

Rosenberg LH, Lafitte M, Quereda V, Grant W, Chen W, Bibian M, Noguchi Y, Fallahi M, Yang C, Chang JC, Roush WR, Cleveland JL, Duckett DR.

Sci Transl Med. 2015 Dec 16;7(318):318ra202. doi: 10.1126/scitranslmed.aac8773.


MDCT features of hepatocellular carcinoma (HCC) in non-cirrhotic liver.

Lafitte M, Laurent V, Soyer P, Ayav A, Balaj C, Petit I, Hossu G.

Diagn Interv Imaging. 2016 Mar;97(3):355-60. doi: 10.1016/j.diii.2015.09.007. Epub 2015 Nov 3.


Identification of an EGFRvIII-JNK2-HGF/c-Met-Signaling Axis Required for Intercellular Crosstalk and Glioblastoma Multiforme Cell Invasion.

Saunders VC, Lafitte M, Adrados I, Quereda V, Feurstein D, Ling Y, Fallahi M, Rosenberg LH, Duckett DR.

Mol Pharmacol. 2015 Dec;88(6):962-9. doi: 10.1124/mol.115.097774. Epub 2015 Oct 9.


High sensitivity C reactive protein, fibrinogen levels and the onset of major depressive disorder in post-acute coronary syndrome.

Lafitte M, Tastet S, Perez P, Serisé MA, Grandoulier AS, Aouizerate B, Sibon I, Capuron L, Couffinhal T.

BMC Cardiovasc Disord. 2015 Mar 18;15:23. doi: 10.1186/s12872-015-0015-3.


Development of an HTS-Compatible Assay for the Discovery of Ulk1 Inhibitors.

Rosenberg LH, Lafitte M, Grant W, Chen W, Cleveland JL, Duckett DR.

J Biomol Screen. 2015 Aug;20(7):913-20. doi: 10.1177/1087057115579391. Epub 2015 Apr 7.


Negative impact of physician prescribed drug dosing schedule requirements on patient adherence to cardiovascular drugs.

Martin-Latry K, Cazaux J, Lafitte M, Couffinhal T.

Pharmacoepidemiol Drug Saf. 2014 Oct;23(10):1088-92. doi: 10.1002/pds.3608. Epub 2014 Mar 19.


Education and home based training for intermittent claudication: functional effects and quality of life.

Prévost A, Lafitte M, Pucheu Y, Couffinhal T; on behalf the CEPTA educational team.

Eur J Prev Cardiol. 2015 Mar;22(3):373-9. doi: 10.1177/2047487313512217. Epub 2013 Oct 31.


Radiologic-pathologic correlation in liver angiomyolipoma in a 68-year-old woman.

Lafitte M, Ayav A, Bressenot A, Claudon M, Regent D, Laurent V.

Diagn Interv Imaging. 2013 Nov;94(11):1161-4. doi: 10.1016/j.diii.2013.03.004. Epub 2013 Sep 19. No abstract available.


FGFR3 has tumor suppressor properties in cells with epithelial phenotype.

Lafitte M, Moranvillier I, Garcia S, Peuchant E, Iovanna J, Rousseau B, Dubus P, Guyonnet-Dupérat V, Belleannée G, Ramos J, Bedel A, de Verneuil H, Moreau-Gaudry F, Dabernat S.

Mol Cancer. 2013 Jul 31;12:83. doi: 10.1186/1476-4598-12-83.


[Benefit of a short atherosclerosis prevention program on post-stroke vascular risk reduction].

Kazadi A, Sibon I, Lafitte M, Pucheu Y, Renou P, Rouanet F, Couffinhal T.

Rev Neurol (Paris). 2013 Apr;169(4):314-20. doi: 10.1016/j.neurol.2012.09.017. Epub 2013 Feb 21. French.


Comprehensive analysis of PTEN status in breast carcinomas.

Jones N, Bonnet F, Sfar S, Lafitte M, Lafon D, Sierankowski G, Brouste V, Banneau G, Tunon de Lara C, Debled M, MacGrogan G, Longy M, Sevenet N.

Int J Cancer. 2013 Jul 15;133(2):323-34. doi: 10.1002/ijc.28021. Epub 2013 Feb 12.


In vivo gene transfer targeting in pancreatic adenocarcinoma with cell surface antigens.

Lafitte M, Rousseau B, Moranvillier I, Taillepierre M, Peuchant E, Guyonnet-Dupérat V, Bedel A, Dubus P, de Verneuil H, Moreau-Gaudry F, Dabernat S.

Mol Cancer. 2012 Oct 22;11:81. doi: 10.1186/1476-4598-11-81.


Very low levels of HDL cholesterol and atherosclerosis, a variable relationship--a review of LCAT deficiency.

Savel J, Lafitte M, Pucheu Y, Pradeau V, Tabarin A, Couffinhal T.

Vasc Health Risk Manag. 2012;8:357-61. doi: 10.2147/VHRM.S29985. Epub 2012 Jun 5. Review.


Dual antiplatelet therapy after myocardial infarction and percutaneous coronary intervention: analysis of patient adherence using a French health insurance reimbursement database.

Latry P, Martin-Latry K, Lafitte M, Peter C, Couffinhal T.

EuroIntervention. 2012 Apr;7(12):1413-9. doi: 10.4244/EIJV7I12A221.


Predictors of cardiovascular prognosis in patients receiving optimized secondary prevention measures after acute coronary syndrome.

Lafitte M, Pucheu Y, Latry K, Dijos M, Casassus E, Couffinhal T.

Eur J Prev Cardiol. 2013 Apr;20(2):283-90. doi: 10.1177/2047487311434107. Epub 2012 Jan 6.


Fast track echo of abdominal aortic aneurysm using a real pocket-ultrasound device at bedside.

Dijos M, Pucheux Y, Lafitte M, Réant P, Prevot A, Mignot A, Barandon L, Roques X, Roudaut R, Pilois X, Lafitte S.

Echocardiography. 2012 Mar;29(3):285-90. doi: 10.1111/j.1540-8175.2011.01559.x. Epub 2011 Nov 8.


Supplemental Content

Loading ...
Support Center